Categories: BioTechDevelopmentDiagnosticsDrugHealthTechMedtechProductResearchTechnologyTools
We address health issues on a global scale by pioneering ways to diagnose and treat diseases.
Location: United States, New York
Investors 1
Mentions in press and media 7
| Date | Title | Description |
| 15.09.2022 | Mirimus Monkeypox Laboratory Developed Test (LDT) Approved | NEW YORK (PRWEB) September 15, 2022
Mirimus, a leading provider of high-quality virology testing, launched its lab-developed test (LDT) for monkeypox detection. The test is a highly sensitive and specific PCR assay with the ability to detec... |
| 19.07.2021 | Mirimus, Inc. Announces Publication of Research in The Lancet-Affiliated Journal EClinicalMedicine Discussing Pooled, Saliva-Based COVID-19 Testing as Efficient, Affordable Surveillance Approach for K... | |
| 20.04.2021 | Mirimus, Inc. Partners with St. John's Athletics to Enable COVID-19 Surveillance Testing of Student Athletes Using Pioneering SalivaClear Pooled Testing Platform | |
| 08.03.2021 | Mirimus, Inc. Partners with Eckerd College to Enable COVID-19 Surveillance Testing of Staff and Students Using Pioneering SalivaClear Testing Platform | |
| 22.02.2021 | Mirimus, Inc. Announces Publication of Scientific Paper Highlighting Pooled Saliva-Based Testing as an Effective, Cost-Efficient Approach to COVID-19 Surveillance Testing for Schools | |
| 16.02.2021 | Mirimus, Inc. Partners with The Pingry School to Enable COVID-19 Surveillance Testing of Faculty, Staff, and Students Using Pioneering SalivaClear Testing Platform | |
| 09.11.2020 | Mirimus, Inc. Partners with Wellesley Public Schools to Enable COVID-19 Surveillance Testing of Staff and Students Using Pioneering SalivaClear Pooled Testing Platform | |
Reviews 0
